We are a digital eye health company that designs software for virtual reality (VR) to conduct diagnostic testing and therapeutics with artificial intelligence analytics. Our broader mission at Envision is to capitalize on the insights we can gain from the eye to personalize health care. From the eyes, we can detect not only eye diseases but also neurologic and systemic conditions such as cardiovascular disease. But our first, immediate goal at Envision is to prevent and treat blinding illness from glaucoma and later expanding to other ocular and neurological disease
Lama A. Al-Aswad, MD, MPH
Chief Executive Officer
She is a key opinion leader in the field of ophthalmology, specifically in innovation. She was previously director of ophthalmologic innovation and AI and a leader in tele-medicine at NYU and has extensive experience working with industry on remote technologies and ophthalmic devices. She started a mobile tele-eye care screening unit for ocular health, and implemented the for first kiosk for ophthalmology to improve access to care in underserved areas in NYC. She has served as an Primary Investigator, Investigator and Co-investigator in 30 clinical trials and serves or has served on the editorial board of Ophthalmology Glaucoma, Ophthalmology Science, and EyeNet. She has served as an editor and reviewer for numerous ophthalmologic journals.
Chief Creative Officer
Game and Software Developer in New York City. He majored in Game Design at New York University and was among the first class to graduate from their undergraduate program. I have had a passion for creating games for many years now and am following that passion professionally.
Dinah Chen, MD
She is an NYU-trained ophthalmologist and former chief resident, is the innovation fellow at NYU ophthalmology, where she is working on AI and device development. She completed medical school at Case Western and her undergraduate studies in public policy and international affairs at Princeton University. With a background in global health she has worked for the World Health Organization in Geneva, Switzerland. Her policy work includes early development work to establish a Tobacco Control Center in sub-Saharan Africa and value-based care initiatives, domestically.
Ridwan Shabsigh, MD, FACS
Chairman, Department of Surgery, SBH Health System, Bronx; professor of clinical urology, Weill-Cornell Medical School, and affiliate professor of medicine at CUNY School of Medicine, New York, USA. Dr. Shabsigh received his medical degree from Damascus University Medical School and did 2 urology residencies in Germany and the USA. He completed a residency in urology and a fellowship in sexual medicine, urinary incontinence, and urologic prostheses at Baylor College of Medicine in Houston, USA. Dr. Shabsigh is a Fellow of the American College of Surgeons, a Diplomate of the American Board of Urology, and an active member of several professional societies. He is also the past president of the International Society of Men’s Health and the editor-in-chief of the Journal of Men’s Health.
A leading clinician and researcher in urology, sexual medicine and men’s health, Dr. Shabsigh has participated in numerous clinical trials on investigational drugs for the treatment of sexual dysfunctions. Over the past 30 years, Dr. Shabsigh provided consulting services to the pharma and medical device industries in a broad scope, ranging from pre-clinical to all phases of clinical research and development, with involvement in strategy, multidisciplinary commercialization teams and internal and external professional affairs. He is a frequent contributor to the medical press and has authored numerous original papers and abstracts in addition to review articles, book chapters, and editorials, in journals such as the New England Journal of Medicine, Lancet, British Medical Journal and the Journal of Urology.
He was the manager and IT expert of the NYU ophthalmology innovation lab. He has decades of experience establishing/overseeing multiple mobile screening units through prior work as the director of operations at The Friends of the Congressional Glaucoma Caucus Foundation and at NYU. Vipul designed/prototyped a remote vision-screening, app the NYU EyeTest, which is EMR-integrated.
Iván Marín-Franch trained initially as a statistician in the Universidad de Granada in Spain and after a 4-year period working in the private sector as software engineer, he took up a PhD scholarship with David H Foster in the Department of Optometry & Neuroscience at the University of Manchester on information theory and statistics of color images of natural scenes. He received his PhD in 2009 and has since worked in vision science in ophthalmology and optometry. During his more than 15 years in vision research, he has published over 35 theoretical and experimental papers on a wide variety of topics in vision research, including retinal anomalies such as glaucoma, accommodation, myopia, optical aberrations, and adaptive optics, most of them in top-quartile vision, ophthalmology, and optometry journals. Iván has given lectures on statistics, optics, bioethics, and effective writing and presentation of scientific content to Master's and PhD students. He has also collaboratively developed open-source software for a wide variety of applications, such as the Open Perimetry Interface (OPI), visualFields, a driver to use Android phones as Head-Mounted Displays for perimetry, and non-parametric estimators of Shannon’s information-theoretic measurements.